Dr Reddys Laboratories Ltd News
Tata Motors hits 52-week high ahead of Q4 results; soars 32% so far in CY23
Brokerage firms are expecting a strong recovery in Tata Motor's financials as supply-side issues are relaxing (for JLR) and commodity headwinds are easing (for PV and CV).
 "Tata Motors hits 52-week high ahead of Q4 results; soars 32% so far in CY23")
Overall breadth needs to improve for a reversal in Indian market
Over half of the Nifty 500 stocks are trading below 200-DMA, this points to a weak strength. Market breadth needs to improve if further highs are to be set
 "Overall breadth needs to improve for a reversal in Indian market")
Bias for Nifty likely to remain bearish below 17,210: HDFC Securities
Among individual stocks, the technical & derivative analyst from HDFC Securities recommends to Buy Mahanagar Gas and Dr.Reddy's Labs.
 "Bias for Nifty likely to remain bearish below 17,210: HDFC Securities")
Eris down 4% in 2 days post acquisition of 9 derma brands from Dr Reddy's
Eris Life said that the transaction would help augment and expand cosmetic dermatology business of the company through their product offerings
 "Eris down 4% in 2 days post acquisition of 9 derma brands from Dr Reddy's")
Dr Reddy's acquires Mayne Pharma's USA prescription portfolio for $105 mn
The acquisition will complement DRL's US retail prescription pharmaceutical business with limited competition products
 "Dr Reddy's acquires Mayne Pharma's USA prescription portfolio for $105 mn")
Stay selective on defensives amid current market volatility: Analysts
Given the uncertainty on how the market trajectory may play out ahead, analysts believe investors can rotate allocation from high beta stocks to defensive plays albeit selectively
 "Stay selective on defensives amid current market volatility: Analysts")
Here's why Vinay Rajani is bullish on Dr Reddy's, Oracle Financial Services
As per the technical analyst, the Budget session high of 17,973 and low of 17,353 have become crucial levels to watch out for any directional move in the Nifty index
 "Here's why Vinay Rajani is bullish on Dr Reddy's, Oracle Financial Services")
DRL posts strong 77% profit growth to Rs 1,247 cr riding on US, Russia
Firm says sustained focus on improving productivity has also helped boost profits; DRL is now bullish on its biosimilars and hopes to start filing for them in US in the coming quarters
RIL, Dr Reddy's Labs: 5 Nifty500 stocks cross 200-DMA, defying weak trend
Following a strong close over the 200-DMA set at Rs 2,559, the chart structure of Reliance Industries reveals a "Double Bottom" breakout
 "RIL, Dr Reddy's Labs: 5 Nifty500 stocks cross 200-DMA, defying weak trend")
Strong US pipeline, sustained growth trajectory main trigger for Dr Reddy's
Excluding the strong US show led by Revlimid, Q2 was a mixed bag
 "Strong US pipeline, sustained growth trajectory main trigger for Dr Reddy's")
